Call Options

14 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 14, 2022

BUY
$292.08 - $329.01 $4.24 Million - $4.77 Million
14,500 Added 181.25%
22,500 $7.4 Million
Q3 2021

Nov 15, 2021

BUY
$272.21 - $332.43 $2.18 Million - $2.66 Million
8,000 New
8,000 $2.44 Million
Q2 2021

Aug 16, 2021

SELL
$225.08 - $271.69 $2.52 Million - $3.04 Million
-11,200 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$212.38 - $245.9 $2.17 Million - $2.51 Million
10,200 Added 1020.0%
11,200 $2.52 Million
Q4 2020

Feb 16, 2021

SELL
$212.5 - $245.46 $212,500 - $245,460
-1,000 Reduced 50.0%
1,000 $222,000
Q1 2020

May 15, 2020

SELL
$121.39 - $169.05 $72,834 - $101,430
-600 Reduced 23.08%
2,000 $277,000
Q4 2019

Feb 14, 2020

SELL
$133.47 - $153.48 $1.33 Million - $1.53 Million
-10,000 Reduced 79.37%
2,600 $399,000
Q3 2019

Nov 14, 2019

BUY
$135.4 - $146.47 $1.1 Million - $1.19 Million
8,100 Added 180.0%
12,600 $1.82 Million
Q2 2019

Aug 14, 2019

BUY
$124.88 - $143.73 $274,736 - $316,206
2,200 Added 95.65%
4,500 $643,000
Q1 2019

May 15, 2019

BUY
$97.62 - $132.29 $224,526 - $304,267
2,300 New
2,300 $304,000
Q4 2018

Feb 14, 2019

SELL
$94.85 - $109.54 $3.16 Million - $3.65 Million
-33,300 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$98.13 - $108.9 $2.34 Million - $2.59 Million
-23,800 Reduced 41.68%
33,300 $3.62 Million
Q2 2018

Aug 14, 2018

BUY
$96.1 - $103.24 $2.26 Million - $2.43 Million
23,500 Added 69.94%
57,100 $5.64 Million
Q1 2018

May 15, 2018

BUY
$92.16 - $103.8 $3.1 Million - $3.49 Million
33,600 New
33,600 $3.29 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $153B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.